CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病预防

Abstract

Recommended Article

Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial Adenosine and adenosine receptor-mediated action in coronary microcirculation Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes Clinical Risk Factors and Atherosclerotic Plaque Extent to Define Risk for Major Events in Patients Without Obstructive Coronary Artery Disease: The Long-Term Coronary Computed Tomography Angiography CONFIRM Registry

Original Research2019 Feb 12;139(7):965-980.

JOURNAL:Circulation. Article Link

Circadian-Regulated Cell Death in Cardiovascular Diseases

Rabinovich-Nikitin I, Lieberman B, Martino TA et al. Keywords: biology; cardiovascular diseases; circadian rhythm; ischemia; science; translational medical research

FULL TEXT PDF